From: Timeline representation of clinical data: usability and added value for pharmacovigilance
Participant | Average quality, usual method | Average quality, timeline | Overall average quality |
---|---|---|---|
Participant no. 1 | 0.87 | 0.81 | 0.84 |
Participant no. 2 | 0.81 | 0.85 | 0.84 |
Participant no. 3 | 0.81 | 0.74 | 0.78 |
Total | 0.83 | 0.80 | 0.81 |